US Stock Market Move | Pharmaceutical stocks in general fell Merck & Co., Inc. (MRK.US) dropped more than 3%.
On Tuesday, pharmaceutical stocks tumbled, with Merck (MRK.US) falling more than 3%, GlaxoSmithKline (GSK.US) dropping nearly 3%, and AstraZeneca (AZN.US) falling over 1%.
On Tuesday, pharmaceutical stocks fell across the board, with Merck & Co., Inc. (MRK.US) dropping by over 3%, GlaxoSmithKline plc Sponsored ADR (GSK.US) falling by nearly 3%, and Astrazeneca PLC Sponsored ADR (AZN.US) dropping by over 1%. On the news front, Bryan Garnier, a pan-European investment bank analyst, stated in a report that although it is still uncertain whether the drug "most favored nation" pricing policy proposed by the Trump administration will receive enough political support in Congress, it remains a major burden for the pharmaceutical industry.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


